Entero Healthcare Solutions has announced a board meeting to approve an amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.

The updated policy designates the Managing Director & CEO to appoint a Chief Investor Relations Officer (CIRO) responsible for timely and fair disclosure of price-sensitive information.

The code emphasizes prompt, transparent communication through various media, including the company website, and sets guidelines for interactions with analysts and institutional investors to ensure consistent public disclosure and manage market rumors effectively.